Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Yun-Chang Zhang, Pei-Yu Zeng, Zhi-Qiang Ma, Zi-Yue Xu, Ze-Kun Wang, Beibei Guo, Feng Yang & Zhan-Ting Li. (2022) A pH-responsive complex based on supramolecular organic framework for drug-resistant breast cancer therapy. Drug Delivery 29:1, pages 128-137.
Read now
Read now
Yun-Chang Zhang, Pei-Yu Zeng, Zhi-Qiang Ma, Zi-Yue Xu, Ze-Kun Wang, Beibei Guo, Feng Yang & Zhan-Ting Li. (2022) A pH-responsive complex based on supramolecular organic framework for drug-resistant breast cancer therapy. Drug Delivery 29:1, pages 1-9.
Read now
Read now
Mona Khafaji, Masoud Zamani, Manouchehr Vossoughi & Azam Iraji zad. (2019) Doxorubicin/Cisplatin-Loaded Superparamagnetic Nanoparticles As A Stimuli-Responsive Co-Delivery System For Chemo-Photothermal Therapy. International Journal of Nanomedicine 14, pages 8769-8786.
Read now
Read now
Jiongxi Lei, Shuangchen Cong, Maoyuan Song, Wenxi Zhang, Guanghua Peng, Xinru Li & Yan Liu. (2018) Combination of doxorubicin with harmine-loaded liposomes exerting synergistic antitumor efficacy. Drug Development and Industrial Pharmacy 44:4, pages 570-581.
Read now
Read now
Articles from other publishers (31)
Priya Gupta, Yub Raj Neupane, Suhel Parvez, Kanchan Kohli & Yasmin Sultana. (2023) Combinatorial Chemosensitive Nanomedicine Approach for the
Treatment of Breast Cancer. Current Molecular Medicine 23:9, pages 876-888.
Crossref
Crossref
Mayur Aalhate, Srushti Mahajan, Hoshiyar Singh, Santosh Kumar Guru & Pankaj Kumar Singh. (2023) Nanomedicine in therapeutic warfront against estrogen receptor–positive breast cancer. Drug Delivery and Translational Research 13:6, pages 1621-1653.
Crossref
Crossref
Milad Ashrafizadeh, Ali Zarrabi, Ashkan Bigham, Afshin Taheriazam, Yalda Saghari, Sepideh Mirzaei, Mehrdad Hashemi, Kiavash Hushmandi, Hassan Karimi‐Maleh, Ehsan Nazarzadeh Zare, Esmaeel Sharifi, Yavuz Nuri Ertas, Navid Rabiee, Gautam Sethi & Mingzhi Shen. (2023) (Nano)platforms in breast cancer therapy: Drug/gene delivery, advanced nanocarriers and immunotherapy. Medicinal Research Reviews.
Crossref
Crossref
Jonaid Ahmad Malik, Jeba Ajgar Ansari, Sakeel Ahmed, Afreen Khan, Nafees Ahemad & Sirajudheen Anwar. (2023) Nano-drug delivery system: a promising approach against breast cancer. Therapeutic Delivery 14:5, pages 357-381.
Crossref
Crossref
Salma T. Rafik, Jayant S. Vaidya, Alexander J. MacRobert & Elnaz Yaghini. (2023) Organic Nanodelivery Systems as a New Platform in the Management of Breast Cancer: A Comprehensive Review from Preclinical to Clinical Studies. Journal of Clinical Medicine 12:7, pages 2648.
Crossref
Crossref
Pablo Graván, Aixa Aguilera-Garrido, Juan Antonio Marchal, Saúl A. Navarro-Marchal & Francisco Galisteo-González. (2023) Lipid-core nanoparticles: Classification, preparation methods, routes of administration and recent advances in cancer treatment. Advances in Colloid and Interface Science 314, pages 102871.
Crossref
Crossref
Anna Mizielska, Iga Dziechciowska, Radosław Szczepański, Małgorzata Cisek, Małgorzata Dąbrowska, Jan Ślężak, Izabela Kosmalska, Marta Rymarczyk, Klaudia Wilkowska, Barbara Jacczak, Ewa Totoń, Natalia Lisiak, Przemysław Kopczyński & Błażej Rubiś. (2023) Doxorubicin and Cisplatin Modulate miR-21, miR-106, miR-126, miR-155 and miR-199 Levels in MCF7, MDA-MB-231 and SK-BR-3 Cells That Makes Them Potential Elements of the DNA-Damaging Drug Treatment Response Monitoring in Breast Cancer Cells—A Preliminary Study. Genes 14:3, pages 702.
Crossref
Crossref
Minerva, Amrita Bhat, Sonali Verma, Gresh Chander, RajeshwerSingh Jamwal, Bhawani Sharma, Audesh Bhat, Taruna Katyal, Rakesh Kumar & Ruchi Shah. (2023) Cisplatin-based combination therapy for cancer. Journal of Cancer Research and Therapeutics 19:3, pages 530.
Crossref
Crossref
Shuya Wang, Shuangyu Yang, Xiaojia Yang, Dan Deng, Jie Li & Mingqing Dong. (2023) Research Progress of Traditional Chinese Medicine Monomers in Reversing Multidrug Resistance of Breast Cancer. The American Journal of Chinese Medicine 51:03, pages 575-594.
Crossref
Crossref
Obaid Afzal, Abdulmalik S. A. Altamimi, Muhammad Shahid Nadeem, Sami I. Alzarea, Waleed Hassan Almalki, Aqsa Tariq, Bismillah Mubeen, Bibi Nazia Murtaza, Saima Iftikhar, Naeem Riaz & Imran Kazmi. (2022) Nanoparticles in Drug Delivery: From History to Therapeutic Applications. Nanomaterials 12:24, pages 4494.
Crossref
Crossref
Leila Sayed-Tabatabaei, Jaleh Varshosaz, Shaghayegh Haghjooy Javanmard & Sahel Soghrati. (2022) Camouflaged liposomes by 11A4-nanobody for co-delivery of cisplatin and nitroxoline in breast cancer tumors: An in vitro/in vivo study. Journal of Drug Delivery Science and Technology 71, pages 103273.
Crossref
Crossref
Kammila Martins Nicolau Costa, Camila Beatriz Barros Araújo, Ana Lígia Santiago Barros, Mariana Rillo Sato & João Augusto Oshiro-Júnior. 2022.
Gustavo Henrique Rodrigues da Silva, Ludmilla David de Moura, Fabíola Vieira de Carvalho, Gabriela Geronimo, Talita Cesarim Mendonça, Fernando Freitas de Lima & Eneida de Paula. (2021) Antineoplastics Encapsulated in Nanostructured Lipid Carriers. Molecules 26:22, pages 6929.
Crossref
Crossref
Amin Mahoutforoush, Atefeh Solouk, Hamed Hamishehkar, Masoumeh Haghbin Nazarpak & Soheil Abbaspour-Ravasjani. (2021) Novel decorated nanostructured lipid carrier for simultaneous active targeting of three anti-cancer agents. Life Sciences 279, pages 119576.
Crossref
Crossref
Tugce Boztepe, Guillermo R. Castro & Ignacio E. León. (2021) Lipid, polymeric, inorganic-based drug delivery applications for platinum-based anticancer drugs. International Journal of Pharmaceutics 605, pages 120788.
Crossref
Crossref
Peng Xie, Yushu Wang, Dengshuai Wei, Lingpu Zhang, Bin Zhang, Haihua Xiao, Haiqin Song & Xinzhan Mao. (2021) Nanoparticle-based drug delivery systems with platinum drugs for overcoming cancer drug resistance. Journal of Materials Chemistry B 9:26, pages 5173-5194.
Crossref
Crossref
Ali Sartaj, Sanjula Baboota & Javed Ali. (2021) Exploring the therapeutic potential of nanostructured lipid carrier approaches to tackling the inherent lacuna of chemotherapeutics and herbal drugs against breast cancer. Journal of Drug Delivery Science and Technology 63, pages 102451.
Crossref
Crossref
Mohammad Kashif Iqubal, Ashif Iqubal, Khalid Imtiyaz, M Moshahid A. Rizvi, Madan Mohan Gupta, Javed Ali & Sanjula Baboota. (2021) Combinatorial lipid-nanosystem for dermal delivery of 5-fluorouracil and resveratrol against skin cancer: Delineation of improved dermatokinetics and epidermal drug deposition enhancement analysis. European Journal of Pharmaceutics and Biopharmaceutics 163, pages 223-239.
Crossref
Crossref
Aditi D. Fulfager & Khushwant S. Yadav. (2021) Understanding the implications of co-delivering therapeutic agents in a nanocarrier to combat multidrug resistance (MDR) in breast cancer. Journal of Drug Delivery Science and Technology 62, pages 102405.
Crossref
Crossref
Shashank Chaturvedi & Kamla Pathak. 2021. Advanced Drug Delivery Systems in the Management of Cancer. Advanced Drug Delivery Systems in the Management of Cancer
299
318
.
Nupur Shrivastava, Ankit Parikh, Aiswarya Chaudhuri, Javed Ali, Sanjula Baboota & Sanjay Garg. 2021. Nanocarriers for the Delivery of Combination Drugs. Nanocarriers for the Delivery of Combination Drugs
259
305
.
Mahdi Zeinali, Soheil Abbaspour-Ravasjani, Marjan Ghorbani, Afshin Babazadeh, Tannaz Soltanfam, Ana Cláudia Santos, Hamed Hamishehkar & Michael R. Hamblin. (2020) Nanovehicles for co-delivery of anticancer agents. Drug Discovery Today 25:8, pages 1416-1430.
Crossref
Crossref
Nur Mehpare Kocaturk, Yunus Akkoc, Cenk Kig, Oznur Bayraktar, Devrim Gozuacik & Ozlem Kutlu. (2019) Autophagy as a molecular target for cancer treatment. European Journal of Pharmaceutical Sciences 134, pages 116-137.
Crossref
Crossref
Xue-Ling Guo, Xiao-Xuan Kang, Yue-Qi Wang, Xiao-Jie Zhang, Chang-Jian Li, Yang Liu & Li-Bo Du. (2019) Co-delivery of cisplatin and doxorubicin by covalently conjugating with polyamidoamine dendrimer for enhanced synergistic cancer therapy. Acta Biomaterialia 84, pages 367-377.
Crossref
Crossref
Josef Jampílek & Katarína Kráľová. 2019. Nanoarchitectonics in Biomedicine. Nanoarchitectonics in Biomedicine
219
294
.
Sarjana Raikwar, Sonal Vyas, Rajeev Sharma, Nishi Mody, Surbhi Dubey & Suresh P. Vyas. (2018) Nanocarrier-Based Combination Chemotherapy for Resistant Tumor: Development, Characterization, and Ex Vivo Cytotoxicity Assessment. AAPS PharmSciTech 19:8, pages 3839-3849.
Crossref
Crossref
M.L. Cacicedo, G.A. Islan, I.E. León, V.A. Álvarez, I. Chourpa, E. Allard-Vannier, N. García-Aranda, Z.V. Díaz-Riascos, Y. Fernández, S. SchwartzJrJr, I. Abasolo & G.R. Castro. (2018) Bacterial cellulose hydrogel loaded with lipid nanoparticles for localized cancer treatment. Colloids and Surfaces B: Biointerfaces 170, pages 596-608.
Crossref
Crossref
Biki Gupta, Chul Soon Yong & Jong Oh Kim. (2017) Solid matrix-based lipid nanoplatforms as carriers for combinational therapeutics in cancer. Journal of Pharmaceutical Investigation 47:6, pages 461-473.
Crossref
Crossref
Mehdi Sabzichi, Jamal Mohammadian, Roya Bazzaz, Mohammad Bagher Pirouzpanah, Maghsod Shaaker, Hamed Hamishehkar, Hadi Chavoshi, Roya Salehi & Nasser Samadi. (2017) Chrysin loaded nanostructured lipid carriers (NLCs) triggers apoptosis in MCF-7 cancer cells by inhibiting the Nrf2 pathway. Process Biochemistry 60, pages 84-91.
Crossref
Crossref
Joo-Eun Lee, Yeo-Jung Kwon, Hyoung-Seok Baek, Dong-Jin Ye, Eunah Cho, Hyung-Kyoon Choi, Kyung-Soo Oh & Young-Jin Chun. (2017) Synergistic induction of apoptosis by combination treatment with mesupron and auranofin in human breast cancer cells. Archives of Pharmacal Research 40:6, pages 746-759.
Crossref
Crossref
Xiaofang ZhaoYan YangFuli YaoBin XiaoYing ChengChunhong FengChunyan DuanChunyan ZhangYouping LiuHong LiBo XiaoRongyang Dai. (2016) Unfolded Protein Response Promotes Doxorubicin-Induced Nonsmall Cell Lung Cancer Cells Apoptosis via the mTOR Pathway Inhibition. Cancer Biotherapy and Radiopharmaceuticals 31:10, pages 347-351.
Crossref
Crossref